These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29403003)

  • 21. Deletion of Chitinase-3-like 1 accelerates stroke development through enhancement of Neuroinflammation by STAT6-dependent M2 microglial inactivation in Chitinase-3-like 1 knockout mice.
    Im JH; Yeo IJ; Park PH; Choi DY; Han SB; Yun J; Hong JT
    Exp Neurol; 2020 Jan; 323():113082. PubMed ID: 31669069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-metastatic activity induced by the in vivo activation of purified protein derivative (PPD)-recognizing Th1 type CD4+ T cells.
    Shinomiya Y; Harada M; Kurosawa S; Okamoto T; Terao H; Matsuzaki G; Shirakusa T; Nomoto K
    Immunobiology; 1995 Aug; 193(5):439-55. PubMed ID: 8522359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge.
    Krishnan L; Sad S; Patel GB; Sprott GD
    Cancer Res; 2003 May; 63(10):2526-34. PubMed ID: 12750276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
    Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
    Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice.
    Kostense S; Sun WH; Cottey R; Taylor SF; Harmeling S; Zander D; Small PA; Bender BS
    Antiviral Res; 1998 May; 38(2):117-30. PubMed ID: 9707374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity.
    Casares N; Lasarte JJ; de Cerio AL; Sarobe P; Ruiz M; Melero I; Prieto J; Borrás-Cuesta F
    Eur J Immunol; 2001 Jun; 31(6):1780-9. PubMed ID: 11385623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chitinase 3-like 1 drives allergic skin inflammation via Th2 immunity and M2 macrophage activation.
    Kwak EJ; Hong JY; Kim MN; Kim SY; Kim SH; Park CO; Kim KW; Lee CG; Elias JA; Jee HM; Sohn MH
    Clin Exp Allergy; 2019 Nov; 49(11):1464-1474. PubMed ID: 31397016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate-based adjuvants activate tumor-specific Th1 and CD8
    Xu X; Jin Z; Liu Y; Gong H; Sun Q; Zhang W; Zhao L
    Cancer Lett; 2019 Jan; 440-441():94-105. PubMed ID: 30352261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo antitumor effect of cytotoxic T lymphocytes engineered to produce interferon-gamma by adenovirus-mediated genetic transduction.
    Abe J; Wakimoto H; Tsunoda R; Okabe S; Yoshida Y; Aoyagi M; Hirakawa K; Hamada H
    Biochem Biophys Res Commun; 1996 Jan; 218(1):164-70. PubMed ID: 8573124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
    Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
    Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.
    Mattes J; Hulett M; Xie W; Hogan S; Rothenberg ME; Foster P; Parish C
    J Exp Med; 2003 Feb; 197(3):387-93. PubMed ID: 12566422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo tumor suppression activity by T cell-specific T-bet restoration.
    Lee K; Min HJ; Jang EJ; Hong JH; Hwang ES
    Int J Cancer; 2010 Nov; 127(9):2129-37. PubMed ID: 20143391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity.
    Shinozaki Y; Wang S; Miyazaki Y; Miyazaki K; Yamada H; Yoshikai Y; Hara H; Yoshida H
    Int J Cancer; 2009 Mar; 124(6):1372-8. PubMed ID: 19089917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
    Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
    J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL.
    McKenzie MD; Dudek NL; Mariana L; Chong MM; Trapani JA; Kay TW; Thomas HE
    Int Immunol; 2006 Jun; 18(6):837-46. PubMed ID: 16574667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
    J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHI3L1 alleviate acute liver injury by inhibiting Th1 cells differentiation through STAT3 signaling pathway.
    Zhang S; Dai X; Shi Y; Zhu X; Dai Y; Qian X; Gu J
    Ann Transl Med; 2021 Apr; 9(7):529. PubMed ID: 33987227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses.
    Lee CM; He CH; Nour AM; Zhou Y; Ma B; Park JW; Kim KH; Dela Cruz C; Sharma L; Nasr ML; Modis Y; Lee CG; Elias JA
    Nat Commun; 2016 Sep; 7():12752. PubMed ID: 27629921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.